RTX Corp의 합의된 목표 주가는 70개의 최신 애널리스트 평가를 살펴보고 설정되었습니다. 마지막 3개의 애널리스트 평가는 5월 17, 2024, 4월 30, 2024 및 4월 24, 2024에 Wells Fargo, Barclays 및 Citigroup에서 발표되었습니다. Wells Fargo, Barclays 및 Citigroup 사이의 평균 목표 주가는 $117로, 이러한 3개의 애널리스트 평가에서 RTX Corp에 대한 암시된 16.57% upside가 있습니다.
1애널리스트 평가로부터 계산됨
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/17/2024 | Buy Now | 40.48% | Wells Fargo | Matthew Akers | $119 → $141 | Maintains | Overweight | Get Alert |
04/30/2024 | Buy Now | -0.37% | Barclays | David Strauss | $90 → $100 | Maintains | Equal-Weight | Get Alert |
04/24/2024 | Buy Now | 9.59% | Citigroup | Jason Gursky | $95 → $110 | Maintains | Neutral | Get Alert |
04/24/2024 | Buy Now | 9.59% | B of A Securities | Ronald Epstein | $100 → $110 | Maintains | Neutral | Get Alert |
04/24/2024 | Buy Now | 4.61% | UBS | Gavin Parsons | $103 → $105 | Maintains | Neutral | Get Alert |
04/24/2024 | Buy Now | 18.56% | Susquehanna | Charles Minervino | $110 → $119 | Maintains | Positive | Get Alert |
04/08/2024 | Buy Now | 4.61% | Baird | Peter Arment | $94 → $105 | Maintains | Neutral | Get Alert |
04/01/2024 | Buy Now | 19.56% | Wells Fargo | Matthew Akers | $120 → $120 | Maintains | Overweight | Get Alert |
03/19/2024 | Buy Now | 14.58% | TD Cowen | Cai von Rumohr | $106 → $115 | Maintains | Outperform | Get Alert |
03/14/2024 | Buy Now | 19.56% | Wells Fargo | Matthew Akers | $100 → $120 | Upgrade | Equal-Weight → Overweight | Get Alert |
01/30/2024 | Buy Now | -10.33% | Barclays | David Strauss | $75 → $90 | Maintains | Equal-Weight | Get Alert |
01/25/2024 | Buy Now | -0.37% | B of A Securities | Ronald Epstein | $78 → $100 | Upgrade | Underperform → Neutral | Get Alert |
01/24/2024 | Buy Now | -12.32% | RBC Capital | Ken Herbert | → $88 | Reiterates | Sector Perform → Sector Perform | Get Alert |
01/24/2024 | Buy Now | -4.35% | UBS | Gavin Parsons | $93 → $96 | Maintains | Neutral | Get Alert |
01/16/2024 | Buy Now | -6.35% | Baird | Peter Arment | $88 → $94 | Downgrade | Outperform → Neutral | Get Alert |
11/15/2023 | Buy Now | — | Redburn Atlantic | Olivier Brochet | — | Downgrade | Buy → Neutral | Get Alert |
10/25/2023 | Buy Now | -14.32% | Morgan Stanley | Kristine Liwag | $83 → $86 | Maintains | Equal-Weight | Get Alert |
10/11/2023 | Buy Now | -20.29% | UBS | Gavin Parsons | $110 → $80 | Downgrade | Buy → Neutral | Get Alert |
09/29/2023 | Buy Now | -19.3% | Alembic Global | Peter Skibitski | → $81 | Initiates | → Neutral | Get Alert |
09/25/2023 | Buy Now | -18.3% | RBC Capital | Ken Herbert | → $82 | Reiterates | Sector Perform → Sector Perform | Get Alert |
09/25/2023 | Buy Now | -17.31% | Morgan Stanley | Kristine Liwag | $95 → $83 | Maintains | Equal-Weight | Get Alert |
09/18/2023 | Buy Now | -22.29% | Wells Fargo | Matthew Akers | $100 → $78 | Maintains | Equal-Weight | Get Alert |
09/14/2023 | Buy Now | -21.29% | DZ Bank | Robert Czerwensky | → $79 | Downgrade | Buy → Hold | Get Alert |
09/14/2023 | Buy Now | -25.28% | B of A Securities | Ronald Epstein | $95 → $75 | Downgrade | Neutral → Underperform | Get Alert |
09/13/2023 | Buy Now | -13.32% | JP Morgan | Seth Seifman | $100 → $87 | Maintains | Overweight | Get Alert |
09/12/2023 | Buy Now | -1.36% | TD Cowen | Cai von Rumohr | $109 → $99 | Maintains | Outperform | Get Alert |
09/12/2023 | Buy Now | -18.3% | RBC Capital | Ken Herbert | $105 → $82 | Downgrade | Outperform → Sector Perform | Get Alert |
09/12/2023 | Buy Now | -25.28% | Barclays | David Strauss | $100 → $75 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/31/2023 | Buy Now | — | Argus Research | John Eade | — | Downgrade | Buy → Hold | Get Alert |
07/27/2023 | Buy Now | -5.35% | Citigroup | Jason Gursky | $113.5 → $95 | Maintains | Neutral | Get Alert |
07/27/2023 | Buy Now | -5.35% | B of A Securities | Ronald Epstein | $120 → $95 | Downgrade | Buy → Neutral | Get Alert |
07/26/2023 | Buy Now | 9.59% | Susquehanna | Charles Minervino | $117 → $110 | Maintains | Positive | Get Alert |
07/26/2023 | Buy Now | 4.61% | RBC Capital | Ken Herbert | $110 → $105 | Maintains | Outperform | Get Alert |
07/26/2023 | Buy Now | -0.37% | Wells Fargo | Matthew Akers | $98 → $100 | Maintains | Equal-Weight | Get Alert |
07/26/2023 | Buy Now | -5.35% | Morgan Stanley | Kristine Liwag | $110 → $95 | Downgrade | Overweight → Equal-Weight | Get Alert |
06/26/2023 | Buy Now | 9.59% | Morgan Stanley | Kristine Liwag | $115 → $110 | Maintains | Overweight | Get Alert |
06/20/2023 | Buy Now | 9.59% | RBC Capital | Ken Herbert | → $110 | Reiterates | Outperform → Outperform | Get Alert |
04/26/2023 | Buy Now | 13.08% | Citigroup | Jason Gursky | $106 → $113.5 | Maintains | Neutral | Get Alert |
04/26/2023 | Buy Now | 9.59% | RBC Capital | Ken Herbert | → $110 | Reiterates | → Outperform | Get Alert |
04/26/2023 | Buy Now | 16.57% | Susquehanna | Charles Minervino | $116 → $117 | Maintains | Positive | Get Alert |
04/26/2023 | Buy Now | 9.59% | Credit Suisse | Scott Deuschle | $105 → $110 | Maintains | Neutral | Get Alert |
04/26/2023 | Buy Now | 14.58% | Baird | Peter Arment | $106 → $115 | Maintains | Outperform | Get Alert |
04/20/2023 | Buy Now | 9.59% | Jefferies | Sheila Kahyaoglu | $115 → $110 | Downgrade | Buy → Hold | Get Alert |
04/12/2023 | Buy Now | 16.57% | Wolfe Research | Myles Walton | → $117 | Upgrade | Peer Perform → Outperform | Get Alert |
01/26/2023 | Buy Now | 5.61% | Citigroup | Jason Gursky | $104 → $106 | Maintains | Neutral | Get Alert |
01/25/2023 | Buy Now | 6.61% | Wells Fargo | Matthew Akers | $96 → $107 | Maintains | Equal-Weight | Get Alert |
01/25/2023 | Buy Now | 5.61% | Credit Suisse | Scott Deuschle | $103 → $106 | Maintains | Neutral | Get Alert |
01/19/2023 | Buy Now | 14.58% | Morgan Stanley | Kristine Liwag | $119 → $115 | Maintains | Overweight | Get Alert |
01/13/2023 | Buy Now | 4.61% | Goldman Sachs | Noah Poponak | $115 → $105 | Downgrade | Buy → Neutral | Get Alert |
01/12/2023 | Buy Now | 2.62% | Credit Suisse | Scott Deuschle | $83 → $103 | Maintains | Neutral | Get Alert |
12/12/2022 | Buy Now | 6.61% | JP Morgan | Seth Seifman | $102 → $107 | Maintains | Overweight | Get Alert |
12/08/2022 | Buy Now | 3.62% | Citigroup | Jason Gursky | → $104 | Initiates | → Neutral | Get Alert |
10/26/2022 | Buy Now | 5.61% | Baird | Peter Arment | $117 → $106 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | 18.56% | Morgan Stanley | Kristine Liwag | $124 → $119 | Maintains | Overweight | Get Alert |
10/26/2022 | Buy Now | 1.62% | RBC Capital | Ken Herbert | $107 → $102 | Maintains | Outperform | Get Alert |
10/26/2022 | Buy Now | -4.35% | Wells Fargo | Matthew Akers | $98 → $96 | Maintains | Equal-Weight | Get Alert |
10/26/2022 | Buy Now | -17.31% | Credit Suisse | Scott Deuschle | $85 → $83 | Maintains | Neutral | Get Alert |
10/12/2022 | Buy Now | -15.31% | Credit Suisse | Scott Deuschle | → $85 | Initiates | → Neutral | Get Alert |
10/11/2022 | Buy Now | — | Wolfe Research | Myles Walton | — | Initiates | → Peer Perform | Get Alert |
07/27/2022 | Buy Now | -2.36% | Wells Fargo | Matthew Akers | $106 → $98 | Maintains | Equal-Weight | Get Alert |
07/27/2022 | Buy Now | 14.58% | RBC Capital | Ken Herbert | $125 → $115 | Maintains | Outperform | Get Alert |
04/27/2022 | Buy Now | 29.52% | B of A Securities | Ronald Epstein | $115 → $130 | Maintains | Buy | Get Alert |
04/27/2022 | Buy Now | 5.61% | Wells Fargo | Matthew Akers | $96 → $106 | Maintains | Equal-Weight | Get Alert |
04/08/2022 | Buy Now | 24.54% | RBC Capital | Ken Herbert | → $125 | Initiates | → Outperform | Get Alert |
03/10/2022 | Buy Now | 6.61% | Barclays | David Strauss | $100 → $107 | Maintains | Overweight | Get Alert |
03/02/2022 | Buy Now | 23.54% | Morgan Stanley | Kristine Liwag | $118 → $124 | Maintains | Overweight | Get Alert |
01/26/2022 | Buy Now | 17.57% | Morgan Stanley | Kristine Liwag | $110 → $118 | Maintains | Overweight | Get Alert |
01/26/2022 | Buy Now | -4.35% | Wells Fargo | Matthew Akers | $97 → $96 | Maintains | Equal-Weight | Get Alert |
07/29/2021 | Buy Now | -0.37% | Argus Research | John Eade | — | Upgrade | Hold → Buy | Get Alert |
07/28/2021 | Buy Now | 4.61% | Susquehanna | Charles Minervino | — | Maintains | Positive | Get Alert |
RTX (NYSE:RTX)의 최신 목표 주가는 5월 17, 2024에 Wells Fargo에 의해 보고되었습니다. 이 애널리스트 기관은 $141.00에 대한 가격 목표를 설정했으며, 12개월 이내에 RTX이(가) rise될 것으로 예상합니다 (가능한 40.48% upside). 지난 1년간 35개의 애널리스트 기관이 평가를 보고했습니다.
RTX (NYSE:RTX)에 대한 최신 애널리스트 평가는 Wells Fargo에 의해 제공되었으며, RTX은(는) overweight 평가를 유지했다합니다.
RTX Corp에 대한 마지막 업그레이드는 3월 14, 2024에 발생했습니다. 이 때 Wells Fargo는 $120로 가격 목표를 올렸습니다. Wells Fargo는 이전에 RTX Corp에 대해 an equal-weight를 가지고 있었습니다.
RTX Corp에 대한 마지막 다운그레이드는 1월 16, 2024에 발생했습니다. 이 때 Baird가 RTX Corp에 대해 가격 목표를 $88에서 $94로 변경했습니다.
애널리스트들은 주식 평가를 내리기 위해 철저한 연구를 진행합니다. 이 연구에는 공개된 재무 보고서를 검토하고, RTX의 경영진 및 고객과 대화하며, 실적 회의 통화를 듣는 것이 포함됩니다. 대부분의 애널리스트들은 이를 매 분기마다 수행하므로, 한 해에는 회사당 애널리스트 당 4번의 평가를 받을 수 있습니다. RTX에 대한 마지막 평가는 5월 17, 2024에 제출되었으므로, 다음 평가가 5월 17, 2025쯤에 제공될 것으로 예상됩니다.
평가는 주관적이며 변할 수 있지만, 최신 RTX (RTX) 평가는 유지했다로, 가격 목표는 $119.00에서 $141.00으로 조정되었습니다. 현재 RTX (RTX)의 가격은 $100.37로, 이는 애널리스트의 예측 범위에서 out of입니다.
검색 애널리스트 평가 및 가격 목표 모든 주식에 대한